Prospects for the use of ACE inhibitors in patients with coronary artery disease.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy*; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D012039:Regional Blood Flow / Q000187:drug effects; D012084:Renin-Angiotensin System; D012867:Skin / Q000098:blood supply; D014664:Vasodilation; D014666:Vasomotor System / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D002800:Cholinesterase Inhibitors; D007703:Peptidyl-Dipeptidase A